Abstract: The invention relates to pharmaceutical compositions comprising anhydrous(2R,3S)4-acetoxy-2-a-benzoyloxy-5?-20-epoxy-1,7-?-10-?-tri-hydroxy-9-oxo-tax-11-en-13?-il 3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate (I)(docetaxel) and 4-acetoxy-2-?-benzoyloxy-5-?-20-epoxy-1,7?-10-?-tri-hydroxy-9-oxo-tax-11-en-13?-il (2R,3S)3-benzoylamino-2-hydroxy-3-phenylpropionate (II) (paclitaxel), methods for treating neoplastic tumors using anhydrous docetaxel and paclitaxel, and a process for the preparation of the anhydrous docetaxel and paclitaxel.
Type:
Grant
Filed:
August 7, 2008
Date of Patent:
November 6, 2012
Assignees:
Quiral Quimica Do Brasil S.A., Biorganica Ltda.
Inventors:
Marco Antônio Santini, Antônio Machado, Aurélio Maranduba, Eneida Guimarães, Marcio Santiago Junior, Maria Silva
Abstract: Pharmaceutical compositions containing polysorbate 80, anhydrous docetaxel (I) or its trihydrate and an organic acid with a pKa between 2.5-4.5 employed as a degradation inhibitor.
Type:
Application
Filed:
February 9, 2006
Publication date:
September 3, 2009
Applicants:
Quiral Quimica DO Brasil S.A., Biorganica Ltda.
Inventors:
Antonio Machado, Aurelio Maranduba, Eneida Guimaraes, Livia Machado, Marcio Santiago, JR., Maria Silva